D1ME-VRP

N/A

Report date: 2026/03/27 20:01:50

Base Information

Drug NameD1ME-VRP
Drug Alias NameTVDVDENV-1Tetravalent dengue vaccine - Naval Medical Research Center/VicalD1MEPlasmid DNA/recombinant VEE virus replicon particle prime-boost vaccine (US Naval Medical Research Center) +[6] 
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFresh Tracks Therapeutics IncNaval Medical Research Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNaval Medical Research Center
Active IndicationsN/A
Inactive IndicationsDengue

Other Information

ATC CodeN/A
Related LinksN/A